Success Metrics

Clinical Success Rate
91.7%

Based on 11 completed trials

Completion Rate
92%(11/12)
Active Trials
1(6%)
Results Posted
27%(3 trials)
Terminated
1(6%)

Phase Distribution

Ph not_applicable
11
61%
Ph phase_4
2
11%

Phase Distribution

0

Early Stage

0

Mid Stage

2

Late Stage

Phase Distribution13 total trials
Phase 4Post-market surveillance
2(15.4%)
N/ANon-phased studies
11(84.6%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

91.7%

11 of 12 finished

Non-Completion Rate

8.3%

1 ended early

Currently Active

1

trials recruiting

Total Trials

18

all time

Status Distribution
Active(4)
Completed(11)
Terminated(1)
Other(2)

Detailed Status

Completed11
Not yet recruiting3
unknown2
Terminated1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
18
Active
1
Success Rate
91.7%
Most Advanced
Phase 4

Trials by Phase

Phase 42 (15.4%)
N/A11 (84.6%)

Trials by Status

terminated16%
completed1161%
unknown211%
recruiting16%
not_yet_recruiting317%

Recent Activity

Clinical Trials (18)

Showing 18 of 18 trials
NCT07429955Not Applicable

Impact of Pre-operative Sarcopenia on Functional Recovery After Hip Arthroplasty in Older Adults

Not Yet Recruiting
NCT04123431

ACE Acetabular Cup UK Multi-centre PMCF Study

Recruiting
NCT07115732

ACE Acetabular Cup Spanish PMCF Study

Not Yet Recruiting
NCT06659198Not Applicable

Assessing the Perioperative Outcomes of Minimally Invasive Posterior Approach Versus Direct Anterior Approach Total Hip Arthroplasty.

Completed
NCT06410079

Difference in Return to Sports Activity After Hip Arthroplasty by THR or Resurfacing

Not Yet Recruiting
NCT03120312

Short Term and Long Term Outcome for Elderly Patients Treated With Total Hip Replacement

Unknown
NCT04521842Not Applicable

Influence of Femoral Head Size During Total Hip Arthroplasty on Gait

Completed
NCT02171897Not Applicable

Pertrochanter Arthroplasty Versus Osteosynthesis

Completed
NCT02576652Phase 4

Bone Histomorphometry in Postmenopausal Men and Women With Osteoarthritis Undergoing Total Hip Replacement

Completed
NCT03599024Not Applicable

Role of Patient-controlled Epidural Analgesia After Total Hip Replacement

Completed
NCT03076827Not Applicable

Effects of Surgery Start Time on Postoperative Interleukin-6, Interleukin-8, and Cortisol

Completed
NCT00962351Not Applicable

Metal Ion Release From an FDA-Approved Metal-on-Metal Total Hip Replacement Implant

Completed
NCT02338596Phase 4

Ultra-Short Anatomic and Conventional Cementless Stems Cementless Stems in Patients Younger Than Fifty-Five Years Old

Completed
NCT01121146Not Applicable

Study Comparing Marathon Polyethylene and Enduron Polyethylene Acetabular Liners Used in Total Hip Arthroplasty

Completed
NCT01543230Not Applicable

CoMplete™ Acetabular Hip System

Terminated
NCT00208494Not Applicable

Metal on Metal Versus Ceramic on Metal Hip Replacement

Completed
NCT00293605

Effect of Cemented Stem Design on Periprosthetic Bone Mass Following Primary Total Hip Arthroplasty

Completed
NCT00738803Not Applicable

Restoration of Leg Length, Offset, and Center of Rotation in Total Hip Replacement

Unknown

All 18 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
18